ORIGINAL ARTICLE |
|
Year : 2022 | Volume
: 35
| Issue : 3 | Page : 1026-1031 |
|
Assessment of serum level of interleukin-15 in patients with alopecia areata
Mostafa M Soliman1, Eman M Abd El Gayed2, Samar M S Saleh3, Heba A S. Bazid1
1 Department of Dermatology and Andrology, Faculty of Medicine, Menoufia University, Menoufia, Egypt 2 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia University, Menoufia, Egypt 3 Department of Dermatology and Andrology, Kafr El Sheikh Dermatology and Leprosy Hospital, Kafr El Sheikh, Egypt
Correspondence Address:
Samar M S Saleh Mansoura Egypt
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/mmj.mmj_266_21
|
|
Objectives
To evaluate the serum level of interleukin-15 (IL-15) in patients with alopecia areata (AA) in an attempt to verify its role in the pathogenesis of the disease.
Background
AA is a chronic, inflammatory, and autoimmune disease, presenting with nonscarring hair loss. It is a disorder with different clinical presentations. It most commonly affects the scalp, but any hair-bearing area of the skin can be affected.
Patients and methods
A total number of 80 individuals were included in this case–control study; 40 patients with AA and 40 age-matched and sex-matched healthy controls. All cases were randomly selected from the Outpatient Clinic of Kafr El-Sheik Dermatology and Leprosy Hospital. Full history taking (Dermatology and Leprosy Hospital, history), clinical and dermatological examinations were done. IL-15 level was measured using enzyme-linked immunosorbent assay.
Results
IL-15 level was significantly elevated in AA patients (mean level of 62.72 ± 35.66 pg/ml) than in controls (mean level of 35.49 ± 19.72 pg/ml). All the studied parameters such as sex, family history, recurrence, site of the lesion, pattern, and shape had no statistically significant relation with IL-15.
Conclusion
The results obtained may suggest the involvement of IL-15 in the pathogenesis of AA.
|
|
|
|
[FULL TEXT] [PDF]* |
|
|
|